Cargando…

Efficacy and Safety of Cyclosporine versus Tacrolimus in Steroid and Cyclophosphamide Resistant Nephrotic Syndrome: A Prospective Study

Calcineurin inhibitors (CNIs) are the preferred drugs for treatment of childhood steroid-resistant nephrotic syndrome (SRNS) who are also resistant to cyclophosphamide (CYC). Although few studies have shown a benefit of one over the other, efficacy and safety of either CNIs (tacrolimus [TAC] or cycl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prasad, N., Manjunath, R., Rangaswamy, D., Jaiswal, A., Agarwal, V., Bhadauria, D., Kaul, A., Sharma, R., Gupta, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830809/ https://www.ncbi.nlm.nih.gov/pubmed/29515301 http://dx.doi.org/10.4103/ijn.IJN_240_16

Ejemplares similares

Treatment of Steroid and Cyclosporine-Resistant Idiopathic Nephrotic Syndrome in Children
por: Nikibakhsh, A. A., et al.
Publicado: (2011)

Long-Term Follow-Up of Cyclical Cyclophosphamide and Steroids Versus Tacrolimus and Steroids in Primary Membranous Nephropathy
por: Ramachandran, Raja, et al.
Publicado: (2021)

Cyclophosphamide versus cyclosporine A therapy in steroid-resistant nephrotic syndrome: a retrospective study with a mean 5-year follow-up
por: Liu, Yanwei, et al.
Publicado: (2018)

Cyclosporine A and steroid therapy in childhood steroid-resistant nephrotic syndrome
por: Tahar, Gargah, et al.
Publicado: (2010)

Long-Term Efficacy and Safety of Rituximab Versus Tacrolimus in Children With Steroid Dependent Nephrotic Syndrome
por: Basu, Biswanath, et al.
Publicado: (2023)

Experience with tacrolimus in children with steroid-resistant nephrotic syndrome
por: Butani, Lavjay, et al.
Publicado: (2009)

Melding Pharmacogenomic Effect of MDR1 and CYP3A5 Gene Polymorphism on Tacrolimus Dosing in Renal Transplant Recipients in Northern India
por: Prasad, Narayan, et al.
Publicado: (2019)

Comparison of rituximab, cyclophosphamide, and tacrolimus as first steroid-sparing agents for complicated relapsing/steroid-dependent nephrotic syndrome in children: an evaluation of the health-related quality of life
por: Wang, Li, et al.
Publicado: (2022)

A Randomized Controlled Trial of Intravenous versus Oral Cyclophosphamide in Steroid-resistant Nephrotic Syndrome in Children
por: Shah, K. M., et al.
Publicado: (2017)

Efficacy and safety of cyclosporine a for patients with steroid-resistant nephrotic syndrome: a meta-analysis
por: Li, Hong-Yan, et al.
Publicado: (2019)

Use of Cyclosporine Therapy in Steroid Resistant Nephrotic Syndrome (SRNS): A Review
por: Shah, Syed Raza, et al.
Publicado: (2016)

Children with Steroid Dependent Nephrotic Syndrome: Rituximab or Tacrolimus? It’s All in the Timing
por: Qader, Md Abdul, et al.
Publicado: (2023)

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome
por: Dorresteijn, Eiske M., et al.
Publicado: (2008)

Validity of nutrition risk index as a malnutrition screening tool compared with subjective global assessment in end-stage renal disease patients on peritoneal dialysis
por: Prasad, N., et al.
Publicado: (2016)

Cyclosporine/ketoconazole reduces treatment costs for nephrotic syndrome
por: Iyengar, A., et al.
Publicado: (2013)

Measured Glomerular Filtration Rate at Dialysis Initiation and Clinical Outcomes of Indian Peritoneal Dialysis Patients
por: Prasad, N., et al.
Publicado: (2017)

Cyclosporine versus tacrolimus: cost-effectiveness analysis for renal transplantation in Brazil
por: Guerra, Augusto Afonso, et al.
Publicado: (2015)

Efficacy of rituximab versus tacrolimus in difficult-to-treat steroid-sensitive nephrotic syndrome: an open-label pilot randomized controlled trial
por: Mathew, Georgie, et al.
Publicado: (2022)

First known case of catatonia due to cyclosporine A-related neurotoxicity in a pediatric patient with steroid-resistant nephrotic syndrome
por: Heekin, R. David, et al.
Publicado: (2019)

Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria
por: Ladapo, Taiwo Augustina, et al.
Publicado: (2016)

Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome
por: Sinha, A., et al.
Publicado: (2013)

Calcineurin Inhibitors and Neutropenia: Is Cyclosporine Superior to Tacrolimus?
por: Duggal, Tanu, et al.
Publicado: (2019)

Tacrolimus versus cyclophosphamide for patients with idiopathic membranous nephropathy and treated with steroids: a systematic review and meta-analysis of randomized controlled trials
por: Huang, Haiting, et al.
Publicado: (2021)

Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes
por: Manousou, Pinelopi, et al.
Publicado: (2014)

Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine
por: Silva, Jacqueline D., et al.
Publicado: (2023)

The effectiveness of cyclosporine A for patients with steroid-resistant nephrotic syndrome: A protocol for systematic review and meta-analysis
por: Lv, Juan, et al.
Publicado: (2021)

Reciprocal Relationship Between HDAC2 and P-Glycoprotein/MRP-1 and Their Role in Steroid Resistance in Childhood Nephrotic Syndrome
por: Singh, Harshit, et al.
Publicado: (2019)

Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy
por: Zou, Honghong, et al.
Publicado: (2019)

Regulatory and effector T cells changes in remission and resistant state of childhood nephrotic syndrome
por: Jaiswal, A., et al.
Publicado: (2014)

Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
por: Mansell, Holly, et al.
Publicado: (2022)

Intravenous tacrolimus and cyclosporine induced anaphylaxis: what is next?
por: Kang, Sung-Yoon, et al.
Publicado: (2015)

Breastfeeding by a mother taking cyclosporine for nephrotic syndrome
por: Li, Ruizhe, et al.
Publicado: (2022)

Significance of combined cyclosporine−prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial
por: Saito, Takao, et al.
Publicado: (2013)

Chyluria: a mimicker of nephrotic syndrome
por: Kaul, Anupama, et al.
Publicado: (2012)

An Investigation Comparing the Efficacy of Topical Ocular Application of Tacrolimus and Cyclosporine in Dogs
por: Hendrix, Diane V . H., et al.
Publicado: (2011)

Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Posttransplant Diabetes Mellitus
por: Torres, Armando, et al.
Publicado: (2018)

Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis
por: Garming Legert, Karin, et al.
Publicado: (2020)

Deflazacort in comparison to other steroids for nephrotic syndrome
por: Jat, K. R., et al.
Publicado: (2012)

Tacrolimus-induced mania in a patient with nephrotic syndrome
por: Kumar, Alok, et al.
Publicado: (2020)

Optimization of Treatment Modality in Elderly End-stage Renal Disease Population: Peritoneal Dialysis versus Transplant
por: Kaul, A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8e4gs7gkmri8s1bqp97s9nqteo